1,3-dipropyl-8-cyclopentylxanthine has been researched along with Atrophy in 1 studies
DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Robledo, P | 1 |
| Ursu, G | 1 |
| Mahy, N | 1 |
1 other study available for 1,3-dipropyl-8-cyclopentylxanthine and Atrophy
| Article | Year |
|---|---|
Effects of adenosine and gamma-aminobutyric acid A receptor antagonists on N-methyl-D-aspartate induced neurotoxicity in the rat hippocampus.
Topics: Animals; Atrophy; Caffeine; Functional Laterality; GABA-A Receptor Antagonists; Hippocampus; Male; M | 1999 |